{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:37:30Z","timestamp":1758638250651,"version":"3.44.0"},"reference-count":19,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,7,11]]},"abstract":"<jats:p>Polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes (POEMS) syndrome is a rare systemic disease, often unrecognised in the primary care setting. POEMS syndrome is associated with plasma cell dyscrasias and upregulation of vascular endothelial growth factor leading to systemic oedema, papilloedema and pulmonary hypertension. A wide constellation of presenting symptoms often leads to late diagnosis. Unrecognised and untreated disease rapidly leads to death from neuropathic exhaustion or cardiopulmonary failure. Treatment is extrapolated from other plasma cell dyscrasias such as multiple myeloma. Autologous peripheral blood stem cell transplantation (PBSCT) is often an important component of treatment. There is no established standard of care for POEMS syndrome. Therapies include lenalidomide, bortezomib and targeted monoclonal antibodies. We present a patient with POEMS syndrome who achieved rapid complete response to triple therapy consisting of lenalidomide, cyclophosphamide and prednisone, followed by high-dose chemotherapy and PBSCT.<\/jats:p>","DOI":"10.1136\/bcr-2017-223168","type":"journal-article","created":{"date-parts":[[2018,7,27]],"date-time":"2018-07-27T00:25:19Z","timestamp":1532651119000},"page":"bcr-2017-223168","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation"],"prefix":"10.1136","volume":"2018","author":[{"given":"Sarah","family":"Ordway","sequence":"first","affiliation":[{"name":"Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gilbert","sequence":"additional","affiliation":[{"name":"Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Wanko","sequence":"additional","affiliation":[{"name":"Internal Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,7,26]]},"reference":[{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24171"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jns.2010.06.023","article-title":"Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia","volume":"297","author":"Kawano","year":"2010","journal-title":"J Neurol Sci"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.09.045"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/1276759","article-title":"Polyneuropathy as Novel Initial Manifestation in a Case of \"Nonsecretory\" POEMS Syndrome with Sj\u00f6gren\u2019s Syndrome","volume":"2017","author":"Liang","year":"2017","journal-title":"Case Rep Med"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.5","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1212\/WNL.0000000000003405","article-title":"Clinical spectrum of Castleman disease-associated neuropathy","volume":"87","author":"Naddaf","year":"2016","journal-title":"Neurology"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.6","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.03.014","article-title":"Paraneoplastic Progressive Vasculopathy as the Presenting Manifestation of Polyneuropathy, Organomegaly, Endocrinopathy or Edema, M-Spike, and Skin Manifestations: A Case Report","volume":"25","author":"Yaghi","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.7","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.4404.4404","article-title":"Distinctive Genetic Features of Plasma Cells in POEMS Syndrome","volume":"128","author":"Yuhei","year":"2016","journal-title":"Blood"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.8","first-page":"595","article-title":"[Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology]","volume":"60","author":"Misawa","year":"2008","journal-title":"Brain Nerve"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.24267","article-title":"Motor nerve conduction study and muscle strength in newly diagnosed POEMS syndrome","volume":"51","author":"Liu","year":"2015","journal-title":"Muscle Nerve"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s40478-016-0389-1","article-title":"Nerve pathologic features differentiate POEMS syndrome from CIDP","volume":"4","author":"Piccione","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.11","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-300047"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-7143-4"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009157","article-title":"Vascular endothelial growth factor as a predictive marker for POEMS syndrome treatment response: retrospective cohort study","volume":"5","author":"Misawa","year":"2015","journal-title":"BMJ Open"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.14","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2012-304874"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.15","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.869329"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23374"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/bjh.14966","article-title":"Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial","volume":"179","author":"Nozza","year":"2017","journal-title":"Br J Haematol"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S1474-4422(16)30157-0","article-title":"Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"15","author":"Misawa","year":"2016","journal-title":"Lancet Neurol"},{"key":"2025082803462292000_2018.jul25_2.bcr-2017-223168.19","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.148460"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2017-223168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:46:31Z","timestamp":1756377991000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2017-223168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,26]]},"references-count":19,"alternative-id":["10.1136\/bcr-2017-223168"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2017-223168","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,7,26]]}}}